SHL’s New Multi-Fixed-Dose Pen: Elevating Patient Experience and Safety in Weight Management Drug Delivery

At Pharmapack 2026, SHL Medical will unveil its latest innovation: a next-generation automatic multi-fixed-dose pen designed specifically for the rapidly expanding cardiometabolic therapeutics market.

This innovative new product directly addresses needs of biopharma companies launching new weight management drugs, where market differentiation and patient compliance are key.

The pen delivers multiple pre-set doses in a single device, eliminating the risk of dosing errors, thereby meeting critical industry demands for safety and patient-centricity. It utilizes RTU cartridges, which results in streamlined pharma operations, and - through minimizing labeling, packaging, and distribution needs - it delivers substantial sustainability and cost efficiencies.

SHL's mission is to empower patients’ independence. Leveraging decades of expertise, SHL enables home-based treatments that are safer, simpler, and more economical, driving better outcomes for patients and partners alike. Join us to experience the future of weight management drug delivery redefined.